Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Vietnam flag Vietnam · Delayed Price · Currency is VND
139,800
+1,300 (0.94%)
At close: May 18, 2026
Market Cap1.30T +25.6%
Revenue (ttm)559.51B +7.1%
Net Income60.31B -6.4%
EPS6,456.00 -2.0%
Shares Out9.33M
PE Ratio21.65
Forward PEn/a
Dividend6,268.00 (4.49%)
Ex-Dividend DateApr 21, 2026
Volume2,308
Average Volume55,281
Open138,000
Previous Close138,500
Day's Range137,800 - 139,800
52-Week Range100,200 - 189,000
Betan/a
RSI53.09
Earnings DateApr 24, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company manufactures and sells pharmaceutical products in Vietnam. The company offers over the counter drug products, such as medicines from medicinal herbs; minerals and vitamins; eye, ENT, and cough treatment; disinfectants; anti-allergic drugs; gastrointestinal and hepatobiliary drugs; external medications; drugs to treat parasites and bacterial infections analgesic, antipyretic, anti-inflammatory, and gout treatment; cardiovascular and diabetes; and psychoactive drugs. It is also involved in th... [Read more]

Founded 1981
Employees 516
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PMC
Full Company Profile

Financial Performance

In 2025, HNX:PMC's revenue was 546.57 billion, an increase of 9.71% compared to the previous year's 498.18 billion. Earnings were 60.08 billion, an increase of 2.71%.

Financial Statements